Literature DB >> 9804380

Transgenic and knockout mice in research on prion diseases.

A J Raeber1, S Brandner, M A Klein, Y Benninger, C Musahl, R Frigg, C Roeckl, M B Fischer, C Weissmann, A Aguzzi.   

Abstract

Since the discovery of the prion protein (PrP) gene more than a decade ago, transgenetic investigations on the PrP gene have shaped the field of prion biology in an unprecedented way. Many questions regarding the role of PrP in susceptibility of an organism exposed to prions have been elucidated. For example mice with a targeted disruption of the PrP gene have allowed the demonstration that an organism that lacks PrPc is resistant to infection by prions. Reconstitution of these mice with mutant PrP genes allowed investigations on the structure-activity relationship of the PrP gene with regard to scrapie susceptibility. Unexpectedly, transgenic mice expressing PrP with specific amino-proximal truncations spontaneously develop a neurologic syndrome presenting with ataxia and cerebellar lesions. A distinct spontaneous neurologic phenotype was observed in mice with internal deletions in PrP. Using ectopic expression of PrP in PrP knockout mice has turned out to be a valuable approach towards the identification of host cells that are capable of replicating prions. Transgenic mice have also contributed to our understanding of the molecular basis of the species barrier for prions. Finally, the availability of PrP knockout mice and transgenic mice overexpressing PrP allows selective reconstitution experiments aimed at expressing PrP in neurografts or in specific populations of hemato- and lymphopoietic cells. Such studies have shed new light onto the mechanisms of prion spread and disease pathogenesis.

Entities:  

Mesh:

Year:  1998        PMID: 9804380     DOI: 10.1111/j.1750-3639.1998.tb00197.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  10 in total

1.  Prion proteins and the gut: une liaison dangereuse?

Authors:  A N Shmakov; S Ghosh
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Mapping the parameters of prion-induced neuropathology.

Authors:  M P Stumpf; D C Krakauer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 3.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

4.  Helicobacter pylori upregulates prion protein expression in gastric mucosa: a possible link to prion disease.

Authors:  Peter C Konturek; Karolina Bazela; Vitaliy Kukharskyy; Michael Bauer; Eckhart G Hahn; Detlef Schuppan
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

5.  Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine prp.

Authors:  J L Vilotte; S Soulier; R Essalmani; M G Stinnakre; D Vaiman; L Lepourry; J C Da Silva; N Besnard; M Dawson; A Buschmann; M Groschup; S Petit; M F Madelaine; S Rakatobe; A Le Dur; D Vilette; H Laude
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies.

Authors:  Hanna Lewicki; Antoinette Tishon; Dirk Homann; Honoré Mazarguil; Françoise Laval; Valerie C Asensio; Iain L Campbell; Stephen DeArmond; Bryan Coon; Chao Teng; Jean Edouard Gairin; Michael B A Oldstone
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC.

Authors:  Sandra Müller; Roland Kehm; Michaela Handermann; Nurith J Jakob; Udo Bahr; Björn Schröder; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

8.  NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells.

Authors:  Benoît Schneider; Vincent Mutel; Mathéa Pietri; Myriam Ermonval; Sophie Mouillet-Richard; Odile Kellermann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 9.  Gene expression resulting from PrPC ablation and PrPC overexpression in murine and cellular models.

Authors:  Franc Llorens; Isidre Ferrer; José Antonio del Río
Journal:  Mol Neurobiol       Date:  2013-08-16       Impact factor: 5.590

10.  Characterization of four new monoclonal antibodies against the distal N-terminal region of PrP(c).

Authors:  Alessandro Didonna; Anja Colja Venturini; Katrina Hartman; Tanja Vranac; Vladka Čurin Šerbec; Giuseppe Legname
Journal:  PeerJ       Date:  2015-03-19       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.